Clinical Nurse Specialist in Taunton, MA Accepting Medicare

6 Clinical Nurse Specialist nurses found. Showing 1 - 6

Donna Marie Amaral, PMHCNS-BC Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7 Dean St, Taunton, MA 02780 Phone: 508-822-0006

Mrs. Susan Irene Cullen, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 60 Hodges Ave Ext, Taunton Hospital, Taunton, MA 02780 Phone: 508-977-3000    Fax: 508-977-3208

Ms. Gail Elizabeth Polli, APRN,PC Clinical Nurse Specialist - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 1 Washington St, Taunton, MA 02780 Phone: 617-376-3000

Mr. Michael Eugene Sweeney Jr., RN PC, PMHCNS-BS Clinical Nurse Specialist - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 30 Taunton Grn, Taunton, MA 02780 Phone: 508-880-6666    Fax: 508-880-6655

Ms. Vania Louisa Brown-small, APRN, BC Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 88 Washington St, Taunton, MA 02780 Phone: 508-828-7000

Ms. Linda I Roedder, Clinical Nurse Specialist - Psych/Mental Health, Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 275 Princess Kate Cir, Taunton, MA 02780 Phone: 857-251-2540

News Archive

Merck discontinues MK-1903 niacin receptor agonist development program with Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. announced today Merck and Co., Inc.'s decision (through an affiliate) to discontinue development of MK-1903, an investigational niacin receptor agonist to treat atherosclerosis being developed under its research collaboration with Arena. Merck also informed Arena that the company will not continue the collaboration.

Message of health benefits of moderate drinking are hazardous and extremely dangerous

A Letter to the Editor entitled "What should we advise about alcohol consumption?" was recently published by Maurizio Ponz de Leon in Intern Emerg Med.1 Dr. de Leon argues that the message of health benefits of moderate drinking "seems to me hazardous and extremely dangerous to diffuse in the general population."

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.

Study help researchers develop proven ways to keep kids involved in organized sports

If you think winning is one of the key determinants that makes organized sports fun for kids think again: Winning along with other mental bonuses ranked near the bottom of 81 determinants of fun, each of which falls into one of 11 big fun factors, according to a new study.

Read more Medical News

› Verified 3 days ago